SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-21-000099
Filing Date
2021-05-28
Accepted
2021-05-28 06:04:53
Documents
13
Period of Report
2021-05-28

Document Format Files

Seq Description Document Type Size
1 6-K form6k-3x052821.htm 6-K 11801
2 EX-99.1 shareholder_letter.htm EX-99.1 32783
3 GRAPHIC shareholder_letter001.jpg GRAPHIC 143920
4 GRAPHIC shareholder_letter002.jpg GRAPHIC 147059
5 GRAPHIC shareholder_letter003.jpg GRAPHIC 154238
6 GRAPHIC shareholder_letter004.jpg GRAPHIC 157806
7 GRAPHIC shareholder_letter005.jpg GRAPHIC 167956
8 GRAPHIC shareholder_letter006.jpg GRAPHIC 148245
9 GRAPHIC shareholder_letter007.jpg GRAPHIC 116712
10 GRAPHIC shareholder_letter008.jpg GRAPHIC 136761
11 GRAPHIC shareholder_letter009.jpg GRAPHIC 162266
12 GRAPHIC shareholder_letter010.jpg GRAPHIC 167531
13 GRAPHIC shareholder_letter011.jpg GRAPHIC 123150
  Complete submission text file 0001395064-21-000099.txt   2285687
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 21975892
SIC: 2834 Pharmaceutical Preparations